摘要
Trastuzumab resistance negatively influences the clinical efficacy of the therapy for human epidermal growth factor receptor 2 (HER2) positive gastric cancer (GC), and the underlying mechanisms remain elusive. Exploring the mechanisms and finding effective approaches to address trastuzumab resistance are of great necessity. Here, we confirmed that endoplasmic reticulum (ER) stress-induced trastuzumab resistance by up-regulating miR-301a-3p in HER2-positive GC cells. Moreover, we elucidated that miR-301a-3p mediated trastuzumab resistance by down-regulating the expression of leucine-rich repeats and immunoglobulin-like domains containing protein 1 (LRIG1) and subsequently activating the expression of insulin-like growth factor 1 receptor (IGF-1R) and fibroblast growth factor receptor 1 (FGFR1) under ER stress. We also found that intercellular transfer of miR-301a-3p by exosomes disseminated trastuzumab resistance. The present study demonstrated that exosomal miR-301a-3p could serve as a non-invasive biomarker for trastuzumab resistance, which was maybe a novel potential therapeutic target to overcome trastuzumab resistance and improve the curative effect of trastuzumab in HER2-positive GC patients.
学科与关键词
- Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2-positive gastric cancerHu, Xingbin; Ma, Zhenfeng; Xu, Beibei; Li, Shulong; Yao, Zhiqi; Liang, Bishan; Wang, Jiao; Liao, Wangjun; Lin, Li; Wang, Chunling; Zheng, Siting; Wu, Qijing; Huang, Qiong; Yu, Le; Wang, Fenghua*; Shi, Min*Cancer Communications, 2023, 43(8): 909-937.被引 2
- Inhibition of PFKFB3 in HER2-positive gastric cancer improves sensitivity to trastuzumab by inducing tumour vessel normalisationYao, Xingxing; He, Zhanke; Qin, Caolitao; Zhang, Penghao; Sui, Chuyang; Deng, Xiangqian; Fang, Yuxin; Li, Guoxin*; Shi, Jiaolong*British Journal of Cancer, 2022, 127(5): 811-823.被引 4
- Galectin-3 enhances trastuzumab resistance by regulating cancer malignancy and stemness in HER2-positive breast cancer cellsChen, Yuqiu; Xu, Jiawei; Pan, Wang; Xu, Xiaofan; Ma, Xueping; Chu, Ya'nan; Wang, Lu; Pang, Shuyun; Li, Yujiao; Zou, Bingjie*; Zhou, Guohua*; Gu, Jun*Thoracic Cancer, 2022, 13(13): 1961-1973.被引 2
